布地奈德混懸液聯(lián)合甘氨酸茶堿緩釋片治療慢性阻塞性肺疾病急性加重期的臨床效果

王宏靜　　鄭遠方　　易科成　　譚弘珍　　梅曦丹

[關(guān)鍵詞] 布地奈德混懸液;甘氨酸茶堿緩釋片;霧化;慢性阻塞性肺疾病

[中圖分類號] R563.9? ? ? ? ? [文獻標識碼] A? ? ? ? ? [文章編號] 1673-9701（2021）20-0021-04

Clinical effect of budesonide suspension combined with theophylline glycine sustained-release tablets in the treatment of acute exacerbation of the chronic obstructive pulmonary disease

WANG Hongjing? ?ZHENG Yuanfang? ?YI Kecheng? ?TAN Hongzhen? ?MEI Xidan

Department of Respiratory Medicine，Changde First Hospital of Traditional Chinese Medicine，Changde? ?415000，China

[Abstract] Objective To investigate the clinical effect of budesonide suspension combined with glycine theophylline sustained-release tablets in the treatment of chronic obstructive pulmonary disease in the acute exacerbation period.Methods Sixty patients with acute exacerbation of chronic obstructive pulmonary disease admitted to our hospital from June to November 2020 were selected as the research objects.They were randomly divided into the control group and the experimental group，with 30 cases in each group. Both groups were given conventional treatment.At the same time，patients in the control group were treated with glycine theophylline sustained-release tablets.Patients in the experimental group were treated with budesonide suspension combined with glycine theophylline sustained-release tablets. The clinical effects of the two groups before and after treatment and the safety after medication were compared. Results After seven days of treatment， the total effective rate of the experimental group was higher than that of the control group，and the difference was statistically significant （P<0.05）. PaO2， PaCO2， and FEV1 of the two groups after treatment were better than those before treatment，and the difference was statistically significant （P<0.05）. And the difference between the two groups was statistically significant （P<0.05）. During the treatment period，there was no significant difference between the two groups in terms of palpitation，tremor，dizziness，insomnia，and gastrointestinal discomfort （P>0.05）. Conclusion The combination of budesonide suspension and theophylline glycine sustained-release tablets can improve the clinical symptoms of patients with chronic obstructive pulmonary disease in the acute phase，and has high safety.It is worthy of clinical application.

[Key words] Budesonide suspension;Theophylline glycine sustained-release tablets;Atomization;Chronic obstructive pulmonary disease